Every sector is being impacted by the rise of artificial intelligence. Venture capitalist John Flavin, Co-Founder and CEO of Portal Innovations, says he is using it to find the next biotech company to invest in. Flavin tells Asking for a Trend that his firm has developed an “AI-enabled platform that can predict innovation and start to rank innovative inventors coming out of universities.” He points out that most new drugs start “on the bench at a university several years prior to it becoming a drug.” Flavin wants to find those ideas and scientists early so he can be an early investor in their ventures.
Watch the video above to hear how some of the companies Flavin invested in are using AI.
For more expert insight and the latest market action, click here to watch this full episode of Asking for a Trend.
This post was written by Stephanie Mikulich.
Video Transcript
You know, another trend we talk about here on the show you won’t be surprised to hear is the mega trend of A I I am curious, John, how that technology is impacting and transforming your world, you know, life science is investing.
Yeah.
Well, first, you know, from the aperture of the venture capitalists, um we have developed our own tool called star gaze, which is an A I enabled platform that can predict innovation and start to rank innovative uh inventors coming out of universities.
Remember the lifeblood of a of a new drug starts uh on the bench at a university um several years prior to it becoming a drug.
And so um we’re using this tool to mine the universe to identify who’s working on what hot area of technology.
How do we get there first to make those investments and using the machine learning algorithm, we can use predictive biomarkers to who might be a promising up and coming scientist working on the latest, cutting cutting edge science anywhere in the world, but certainly here in the United States.
Now, if you look at the locations in science, we’ve got a company here in Chicago Tempus, I I, that went public a few weeks back, precision medicine.
So using A I for accelerating, figuring out what drugs are gonna work with which patients in any kind of disease ranging from cancer to, to uh cardio metabolic diseases.
Um You’ve got other companies like Recursion Pharma out in Salt Lake City that’s applying uh tech bio and A I to identifying drugs in both neural and oncology.
Um That space is heating up very quickly and I think you’re gonna see, you know, strong benefits to what’s happening in that regard lastly, really way out there in the future is quantum.
So uh believe it or not quantum is really starting to get applied to life sciences as well.
So the ability to simulate the drug discovery process and take shortcuts and accelerate going from a Petri dish all the way to a patient.
Um I’m really excited about what will happen in the next decade in that area as well.
Source Agencies
